Cargando…

Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma

The objective of the present study was to perform a quantitative analysis of cancer stem cell (CSC) marker expression in ovarian carcinoma effusions. The clinical role of SSEA1 in metastatic high-grade serous carcinoma (HGSC) was additionally analyzed. CD133, Nanog, SOX2, Oct3/4, SSEA1, and SSEA4 pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davidson, Ben, Holth, Arild, Dong, Hiep Phuc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581515/ https://www.ncbi.nlm.nih.gov/pubmed/32472195 http://dx.doi.org/10.1007/s00428-020-02850-4

Ejemplares similares

CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma
por: Nymoen, Dag Andre, et al.
Publicado: (2015)

Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinoma
por: Davidson, Ben, et al.
Publicado: (2020)

Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma
por: Davidson, Ben, et al.
Publicado: (2023)

Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions
por: Davidson, Ben, et al.
Publicado: (2011)

mTORC1 Maintains the Tumorigenicity of SSEA-4(+) High-Grade Osteosarcoma
por: Zhang, Wu, et al.
Publicado: (2015)

Development of Fluorescently Labeled SSEA-3, SSEA-4, and Globo-H Glycosphingolipids for Elucidating Molecular Interactions in the Cell Membrane
por: Asano, Sachi, et al.
Publicado: (2019)

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis
por: Zanotti, Laura, et al.
Publicado: (2017)

Author Correction: mTORC1 Maintains the Tumorigenicity of SSEA-4 (+) High-Grade Osteosarcoma
por: Zhang, Wu, et al.
Publicado: (2021)

Hsp70 (HSPA1) Lysine Methylation Status as a Potential Prognostic Factor in Metastatic High-Grade Serous Carcinoma
por: Jakobsson, Magnus E., et al.
Publicado: (2015)

Bone Marrow SSEA1+ Cells Support the Myocardium in Cardiac Pressure Overload
por: Finan, Amanda, et al.
Publicado: (2013)

Immunoreactivity of Pluripotent Markers SSEA-5 and L1CAM in Human Tumors, Teratomas, and Induced Pluripotent Stem Cells
por: Cassidy, Linda, et al.
Publicado: (2013)

Circulating SSEA-1(+) stem cell-mediated tissue repair in allergic airway inflammation
por: Chiu, Chiao-Juno, et al.
Publicado: (2022)

L1CAM as a prognostic marker in stage I endometrial cancer: a validation study
por: Smogeli, Elisabeth, et al.
Publicado: (2016)

Concurrent Primary Peritoneal Low-Grade Serous Carcinoma and Endometrial High-Grade Serous Carcinoma
por: Lockyer, Megan G., et al.
Publicado: (2015)

Ex vivo expanded SSEA-4+ human limbal stromal cells are multipotent and do not express other embryonic stem cell markers
por: Lim, Moon Nian, et al.
Publicado: (2012)

Lectin binding profiles of SSEA-4 enriched, pluripotent human embryonic stem cell surfaces
por: Venable, Alison, et al.
Publicado: (2005)

Continuous Hypoxic Culturing of Human Embryonic Stem Cells Enhances SSEA-3 and MYC Levels
por: Närvä, Elisa, et al.
Publicado: (2013)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Impact of mutational status on survival in low-grade serous carcinoma of the ovary or peritoneum
por: Gershenson, David M, et al.
Publicado: (2015)

CCNE1 amplification among metastatic sites in patients with gynecologic high-grade serous carcinoma
por: Margolis, Benjamin, et al.
Publicado: (2021)

Metastatic serous endometrial carcinoma to the ureter
por: Sahl, Jessa W., et al.
Publicado: (2021)

A survival analysis comparing women with ovarian low-grade serous carcinoma to those with high-grade histology
por: Chen, Ming, et al.
Publicado: (2014)

Lipid Droplet Accumulation Independently Predicts Poor Clinical Prognosis in High-Grade Serous Ovarian Carcinoma
por: Iwahashi, Naoyuki, et al.
Publicado: (2021)

A Novel Type of Stem Cells Double-Positive for SSEA-3 and CD45 in Human Peripheral Blood
por: Sato, Tetsuya, et al.
Publicado: (2020)

SSEA-4 positive dental pulp stem cells from deciduous teeth and their induction to neural precursor cells
por: Lopez-Lozano, Ada Pricila, et al.
Publicado: (2022)

Neonatal lung-derived SSEA-1(+) cells exhibited distinct stem/progenitor characteristics and organoid developmental potential
por: Liao, Chien-Chia, et al.
Publicado: (2022)

Bilateral Serous Psammocarcinoma of Ovary: Rare Variant Low Grade Serous Carcinoma
por: Jena, Saubhagya Kumar, et al.
Publicado: (2015)

Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma
por: Sharbatoghli, Mina, et al.
Publicado: (2022)

Role of integrins in the metastatic spread of high-grade serous ovarian cancer
por: Krajnak, Slavomir, et al.
Publicado: (2021)

Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray
por: Wang, Shasha, et al.
Publicado: (2019)

High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the “SET” feature of high-grade serous carcinoma to the “STEM” feature
por: Hatano, Yuichiro, et al.
Publicado: (2019)

ZIP4 Is a Novel Cancer Stem Cell Marker in High-Grade Serous Ovarian Cancer
por: Fan, Qipeng, et al.
Publicado: (2020)

The Continuum of Serous Tumors of Low Malignant Potential and Low-Grade Serous Carcinomas of the Ovary
por: Wong, Kwong-Kwok, et al.
Publicado: (2007)

Accelerating skin wound healing by M-CSF through generating SSEA-1 and -3 stem cells in the injured sites
por: Li, Yunyuan, et al.
Publicado: (2016)

Role of glycosphingolipid SSEA‐3 and FGF2 in the stemness and lineage commitment of multilineage differentiating stress enduring (MUSE) cells
por: Aprile, Domenico, et al.
Publicado: (2022)

In vivo modeling of metastatic human high-grade serous ovarian cancer in mice
por: Kim, Olga, et al.
Publicado: (2020)

Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma
por: Norris, Eric J, et al.
Publicado: (2019)

Impact of hemodynamic instability during cytoreductive surgery on survival in high-grade serous ovarian carcinoma
por: Kim, Se Ik, et al.
Publicado: (2022)

Stage, treatment and survival of low‐grade serous ovarian carcinoma in the Netherlands: A nationwide study
por: De Decker, Koen, et al.
Publicado: (2023)

Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase
por: Sehdev, Ann Smith, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_f9ae8au7jjc7kfea6p4ev6e7sc